Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing
Am J Obstet Gynecol
.
2018 Jan;218(1):142-143.
doi: 10.1016/j.ajog.2017.10.037.
Epub 2018 Jan 2.
Authors
G J van Baaren
1
,
M M C Bruijn
2
,
B W Mol
3
Affiliations
1
Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address:
[email protected]
.
2
Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands.
3
Department of Obstetrics and Gynecology, Robinson Institute, School of Medicine, University of Adelaide, Adelaide, Australia.
PMID:
29305007
DOI:
10.1016/j.ajog.2017.10.037
No abstract available
Publication types
Letter